Biomaterial Stirring‑Defoaming Solution


Working Condition Requirements: Thoroughly remove micro‑bubbles incorporated during synthesis, mixing and preparation of biomedical biomaterials (bioceramics, medical polymer materials, tissue‑engineering scaffold materials, drug carrier materials, biodegradable materials, hydrogels, medical adhesives, artificial joint bone cement, dental restoration materials, drug sustained‑release matrices, etc.). Biomaterials feature wide viscosity range, high biological activity and extremely strict requirements for uniformity and purity. After defoaming, materials shall be dense, uniform and bubble‑free, meeting requirements for biocompatibility, mechanical performance and GMP production standards to guarantee safety and effectiveness for clinical applications.

Biomedical Industry Biomaterial Solutions.jpg

Comparison Before and After Improvement

Before Improvement: The biomedical industry imposes stringent material quality requirements. Bubbles directly compromise biosafety and clinical performance of finished products. Conventional processing faces multiple challenges:

• Impaired biocompatibility: Residual bubbles inside biomaterials may trigger inflammatory responses and immune rejection after human implantation, severely endangering biocompatibility and clinical safety.

• Sub‑standard mechanical properties: Bubbles create internal defects within bioceramics, bone cement and other materials, greatly reducing compressive and flexural strength and failing mechanical requirements for implants.

• Uncontrollable drug release: Bubbles in drug carrier materials cause uneven porosity, resulting in poorly‑controlled drug release rates and compromised therapeutic effects & medication safety.

• Inhibited tissue ingrowth: Bubbles in tissue‑engineering scaffolds undermine connectivity and uniformity of pore structures, leading to unsatisfactory cell adhesion and tissue regeneration.

• GMP compliance risks: Traditional defoaming delivers low efficiency and poor consistency, hardly satisfying strict GMP requirements for batch consistency and traceability.

 1734663145114117.jpg

Solution: Tailored to practical demands from biomedical manufacturers, SIENOX provides the SIE‑MIX90 planetary vacuum stirring‑defoaming machine and supporting solutions:

1. Planetary vacuum stirring‑defoaming: Adopt SIE‑MIX90 planetary vacuum stirring‑defoaming machine. Combined revolution‑rotation dual‑motion trajectory realizes three‑dimensional mixing of biomaterials under centrifugal field. Meanwhile vacuum environment lowers bubble escape resistance for efficient removal of micron‑sized bubbles.

2. Low‑temperature defoaming for bio‑activity preservation: Vacuum defoaming under low‑temperature conditions avoids thermal damage to bioactive components such as proteins, growth factors and living cells.

3. Contact‑free mixing: No stirring paddles are used to prevent metal ion leaching and cross‑contamination and satisfy high‑purity requirements for biomaterials.

4. Precise PLC program control: Multiple groups of process parameters (speed, duration, vacuum level, temperature) can be stored. Dedicated programs for various biomaterial formulas can be called with one click to guarantee batch‑to‑batch consistency.

5. GMP‑compliant design: The machine complies with GMP standards, easy‑to‑clean and sterilizable. It supports process validation and data logging to meet regulatory requirements of biomedical industry.

6. Closed‑aseptic operation: Full‑process closed defoaming with optional inert gas purging prevents oxidative degradation and microbial contamination of biomaterials.



Sample Provider: Well‑known domestic biomedical enterprise

Test Conditions

Item

Parameter

Test Model

SIE‑MIX90

Test Material

Biomedical biomaterials

Test Rotation Speed

1800 rpm

Test Duration

4 min

Vacuum Level

-95KPa

Effect Comparison Before and After Stirring‑Defoaming

Biomedical‑Material‑Stirring‑Before‑After‑Comparison.jpg

Comparison Dimension

Before Stirring‑Defoaming

After Stirring‑Defoaming

Bubble Content

Abundant micron‑sized bubbles, non‑uniform material

Bubbles largely eliminated, dense and uniform material

Biocompatibility

Bubbles may induce inflammation and immune responses

Bubble‑free, significantly improved biocompatibility

Mechanical Properties

Internal defects lead to strength degradation

Dense structure, greatly enhanced compressive / flexural strength

Drug Release

Uneven porosity, uncontrollable release rate

Uniform porosity, precise and controllable drug release

Tissue‑engineering Performance

Poor pore connectivity, unsatisfactory cell adhesion

Uniform pore structure conducive to cell ingrowth and tissue regeneration

GMP Compliance

Large batch‑to‑batch deviation, hard‑to‑trace

Good batch consistency, verifiable and traceable process


Mature Application Fields

• Bioceramics (artificial bone, artificial joint, dental implant)

• Medical polymer materials (absorbable suture, medical catheter, artificial blood vessel)

• Tissue‑engineering scaffold materials (bone tissue engineering, cartilage repair, skin regeneration)

• Drug carrier materials (sustained‑release microspheres, nanoparticles, hydrogel drug carriers)

• Biodegradable materials (PLA, PGA, PLGA and other degradable implants)

• Hydrogels (ophthalmic materials, wound dressings, drug delivery systems)

• Medical adhesives (orthopedic bone cement, tissue adhesives)

• Dental restoration materials (impression materials, restoration resin, ceramic slurry)